Economic Observation Network Yong'an Pharmaceutical (002365) has been in a bearish trend in the past 5 days, performing weaker than the market and the industry average. In the past 5 days, the main funds have shown a net outflow overall, with a net proportion lower than the market average. On August 14th, the main funds showed a net outflow overall, with a net proportion close to the market average.

The market attention of this stock is average, and the overall public opinion is neutral. The frequency of institutional research is relatively low, and the overall research report rating has not changed much. The fund holds 0.01% of the shares. The latest quarterly report disclosed a+0.01% change in the holding ratio of active equity funds in the stock, and a -44.22% change in the stock price during the same period. The company has average profitability, average growth ability, average operational ability, and good debt paying ability. The current valuation is in the historical high range and at a relatively high level within the industry. The current price to earnings TTM is 112.6, which is higher than the industry median and has been at 58.56% of individual stocks in the past five years.

The above content is based on publicly available information and does not constitute investment advice.